WPI 526 (Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg)

Generic Name: ethinyl estradiol/norgestimate

Pill imprint WPI 526 has been identified as Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg.

Mononessa is used in the treatment of birth control; abnormal uterine bleeding; ovarian cysts; endometriosis; gonadotropin inhibition and belongs to the drug class contraceptives. Not for use in pregnancy. Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 526

Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg WPI 526
Mononessa
Generic Name:
ethinyl estradiol/norgestimate
Imprint:
WPI
526
Strength:
ethinyl estradiol 0.035 mg / norgestimate 0.25 mg
Color:
Blue
Shape:
Round
Availability:
Prescription only
Drug Class:
Contraceptives
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
52544-0247
Inactive Ingredients:
FD&C Blue No. 2
aluminum oxide
ferric oxide red
carnauba wax
hypromelloses
croscarmellose sodium
lactose
magnesium stearate
polyethylene glycol
corn starch
microcrystalline cellulose
magnesium silicate
titanium dioxide
polysorbate 80

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)